Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophy
IntroductionThe availability of disease modifying therapies in Spinal Muscular Atrophy (SMA) has highlighted the need for more structured registries for collecting reliable information both in treated and untreated individuals. Regulators recommendations have recently become available suggesting how...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Frontiers Media S.A.
2026-06-01
|
| Цуврал: | Frontiers in Neurology |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.frontiersin.org/articles/10.3389/fneur.2026.1833889/full |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
